机器学习分类器用于术前预测肺癌患者支气管动脉化疗栓塞治疗后早期复发
本研究回顾性纳入116例经病理确诊并接受支气管动脉化疗栓塞(BACE)的肺癌患者,基于术前增强CT提取影像组学特征,筛选出9个复发相关特征并构建三种影像组学标签,其中RadscoreLDA联合肿瘤大小、癌胚抗原和胃泌素释放肽前体构建的列线图在训练集和验证集预测复发的AUC分别为0.865和0.867,校准曲线和决策曲线分析显示模型预测概率与实际复发概率拟合良好且具有临床实用性。
要点
- 基于术前增强CT的影像组学列线图可预测肺癌BACE治疗后复发,训练集AUC 0.865、验证集AUC 0.867。
- 联合模型包含RadscoreLDA及肿瘤大小、癌胚抗原、胃泌素释放肽前体三个独立临床预测因子。
- 低风险组较高风险组获得更长的无进展生存期(P < 0.05)。
核心结论
- 基于影像组学和临床预测因子的列线图能有效预测BACE治疗后的肿瘤复发,帮助肿瘤科医生识别潜在复发并改善患者管理和临床决策。
研究设计与样本
- 回顾性研究,纳入116例经病理确诊的肺癌患者,均在BACE治疗前2周内接受增强CT检查并随访超过6个月,在训练队列中用LASSO回归筛选复发相关影像组学特征,分别以LDA、SVM和LR算法构建三种影像组学标签,用单因素和多因素LR分析筛选独立临床预测因子,将最佳影像组学标签与临床预测因子整合为联合模型并绘制列线图,通过ROC曲线、校准曲线和决策曲线分析评估模型性能。
诊断标准与关键数值
- 筛选出9个复发相关影像组学特征并构建RadscoreLDA、RadscoreSVM和RadscoreLR三种标签,根据三种标签的最佳阈值将患者分为低风险组和高风险组;联合模型(RadscoreLDA+肿瘤大小+癌胚抗原+胃泌素释放肽前体)在训练队列和验证队列的AUC分别为0.865和0.867,准确率分别为0.804和0.750。
临床应用与阅片要点
- 作者认为该影像组学列线图可有效预测BACE治疗后的肿瘤复发,使肿瘤科医生能够识别潜在复发并有助于更好的患者管理和临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Bronchial arterial chemoembolization (BACE) was deemed as an effective and safe approach for advanced standard treatment-ineligible/rejected lung cancer patients. However, the therapeutic outcome of BACE varies greatly and there is no reliable prognostic tool in clinical practice. This study aimed to investigate the effectiveness of radiomics features in predicting tumor recurrence after BACE treatment in lung cancer patients.
MATERIALS AND METHODS: A total of 116 patients with pathologically confirmed lung cancer who received BACE treatment were retrospectively recruited. All patients underwent contrast-enhanced CT within 2 weeks before BACE treatment and were followed up for more than 6 months. We conducted a machine learning-based characterization of each lesion on the preoperative contrast-enhanced CT images. In the training cohort, recurrence-related radiomics features were screened by least absolute shrinkage and selection operator (LASSO) regression. Three predictive radiomics signatures were built with linear discriminant analysis (LDA), support vector machine (SVM) and logistic regression (LR) algorithms, respectively. Univariate and multivariate LR analyses were performed to select the independent clinical predictors for recurrence. The radiomics signature with best predictive performance was integrated with the clinical predictors to form a combined model, which was visualized as a nomogram. The performance of the combined model was assessed by receiver operating characteristic curve (ROC), calibration curve, and decision curve analysis (DCA).
RESULTS: Nine recurrence-related radiomics features were screened out, and three radiomics signatures (RadscoreLDA, RadscoreSVM and RadscoreLR) were built based on these features. Patients were classified into the low-risk and high-risk groups based on the optimal threshold of three signatures. Progression-free survival (PFS) analysis showed that patients of low-risk group achieved longer PFS than patients of high-risk group (P < 0.05). The combined model including RadscoreLDA and independent clinical predictors (tumor size, carcinoembryonic antigen and pro-gastrin releasing peptide) achieved the best predictive performance for recurrence after BACE treatment. It yields AUCs of 0.865 and 0.867 in the training and validation cohorts, with accuracy (ACC) of 0.804 and 0.750, respectively. Calibration curves indicated that the probability of recurrence predicted by the model fits well with the actual recurrence probability. DCA showed that the radiomics nomogram was clinically useful.
CONCLUSION: The radiomics and clinical predictors-based nomogram can predict tumor recurrence after BACE treatment effectively, which allowing oncologists to identify potential recurrence and enable better patient management and clinical decision-making.
引用
- Kong, Lai, Jin, et al. Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in Lung Cancer Patients. Acad Radiol. 2023. PMID: 37225529. doi:10.1016/j.acra.2023.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。